IMMURON LIMITED (ABN 80 063 114 045) AND THE BANK OF NEW YORK MELLON As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Amended and Restated Deposit Agreement Dated as of ___________, 2017 AMENDED AND RESTATED DEPOSIT AGREEMENTDeposit Agreement • May 8th, 2017 • Immuron LTD • Pharmaceutical preparations • New York
AMENDED AND RESTATED DEPOSIT AGREEMENT dated as of ___________, 2017, among IMMURON LIMITED, incorporated under the laws of the Commonwealth of Australia (herein called the Company), THE BANK OF NEW YORK MELLON, a New York banking corporation (herein called the Depositary), and all Owners and Holders from time to time of American Depositary Shares issued hereunder.
UNDERWRITING AGREEMENT between IMMURON LIMITED and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters IMMURON LIMITEDUnderwriting Agreement • May 8th, 2017 • Immuron LTD • Pharmaceutical preparations • New York
The undersigned, Immuron Limited, a corporation formed under the laws of Australia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Immuron Limited, the “Company”), hereby confirms its agreement (this “Agreement”) with Joseph Gunnar & Co., LLC. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
WARRANT AGENT AGREEMENTWarrant Agent Agreement • May 8th, 2017 • Immuron LTD • Pharmaceutical preparations • New York
WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of ______________, 2017 (the “Issuance Date”) between Immuron Limited, a company incorporated under the laws of the Commonwealth of Australia (the “Company”), and The Bank of New York Mellon (the “Warrant Agent”).
CONFIDENTIAL DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • May 8th, 2017 • Immuron LTD • Pharmaceutical preparations • Victoria
Immuron Ltd,. an Australian corporation having its principal place of business located at 39 Leveson Street, North Melbourne. Victoria 3051, Australia (Immuron); and
DISTRIBUTION AND LICENSE AGREEMENTDistribution and License Agreement • May 8th, 2017 • Immuron LTD • Pharmaceutical preparations • Delaware
and all patents that derive priority from the same priority document and all other patents and patent applications in the same patent family, including all corresponding national phase filing, divisional application and continuations.
MARKETING AND MASTER DISTRIBUTION AGREEMENTMaster Distribution Agreement • May 8th, 2017 • Immuron LTD • Pharmaceutical preparations
THIS MARKETING AND MASTER DISTRIBUTION AGREEMENT (“Agreement”) made and entered as of this 28 day of June, 2016 (the “Effective Date”), by and between Immuron Limited, a Delaware incorporated organization with a U.S. office address at 1775 Pennsylvania Avenue NW Washington DC 20006 corporation (the “Company”) and UniFirst-First Aid Corporation d/b/a MEDIQUE PRODUCTS, a Maryland corporation (“Distributor”) having an address at 4159 Shoreline Drive, St. Louis, MO 63045.
ContractImmuron LTD • May 8th, 2017 • Pharmaceutical preparations
